{
    "other_tests": [
        {
            "procedure_name": "Continuous Glucose Monitoring System (CGMS)",
            "date": "Not specified",
            "findings": "Continuous glucose monitoring showed normoglycemia over 72 hours after discontinuation of pump therapy.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Ultrasound (US)",
            "date": "At age 2 years",
            "findings": "Asymptomatic cholelithiasis was detected.",
            "changes_over_time": "Treatment with ursodeoxycholic acid was started with some improvement on subsequent US studies."
        },
        {
            "procedure_name": "Growth Monitoring",
            "date": "During first 2 years of somatuline treatment",
            "findings": "A mild, transient growth deceleration was observed, with a shift of height from the 50th to the 35th percentile.",
            "changes_over_time": "Subsequent catch-up growth occurred, and the patient resumed normal growth along the 50th percentile."
        },
        {
            "procedure_name": "Glucose Monitoring",
            "date": "Not specified",
            "findings": "Blood glucose was stabilized after treatment with octreotide via insulin pump.",
            "changes_over_time": "No change in growth pattern or cholelithiasis was observed after switching to lanreotide."
        }
    ]
}